File Download

There are no files associated with this item.

Conference Paper: Effectiveness of the Multi-disciplinary Risk Assessment and Management Programme (RAMP) on Patients with Diabetic Mellitus – The First Year Experience

TitleEffectiveness of the Multi-disciplinary Risk Assessment and Management Programme (RAMP) on Patients with Diabetic Mellitus – The First Year Experience
Authors
Issue Date2013
PublisherHong Kong College of Family Physicians.
Citation
The 3rd Hong Kong Primary Care Conference (HKPCC 2013), Hong Kong, 16 June 2013. In Programme book, 2013, p. 26 How to Cite?
AbstractINTRODUCTION: This study aimed to reveal the post 12-month effectiveness of the Multi-disciplinary Risk Assessment and Management Programme (RAMP) on diabetic patients. METHOD: Evaluation involved eleven clinics from four clusters of the Hospital Authority which had started RAMP before June 2010. A random sampling of 1248 patients enrolled into RAMP for more than one year was compared to age-sex, and disease-severity matched non-RAMP controls on clinical outcomes including HbA1c, blood pressure (BP), and low-density lipoprotein cholesterol (LDL-C), and the estimated 10-year cardiovascular disease (CVD) risk using Framingham risk scores equation to reveal the net benefit of RAMP. Independent t-test and Chi-square tests were used for comparison of continuous data and proportions, respectively. RESULTS: Both RAMP and non-RAMP patients showed a reduction in mean HbA1c, blood pressure, and LDL-C; and an increase in proportions of patients achieving target control of HbA1c ≤ 7%, BP ≤ 130/80 mmHg, and LDL-C ≤ 2.6 mmol/L). RAMP group did not show a significant net reduction in HbA1c compared to non-RAMP group but did show a significant net reduction of 2.61 (1.49) mmHg in SBP (DBP), and LDL-C of 0.17 mmol/L. RAMP reduce 10-year CVD risk by 4.66%, which significantly overwhelmed the 2.46% in control group by 2.2%. DISCUSSION: RAMP helped diabetic patients to improve their control of blood glucose, blood pressure, cholesterol level, and reduce their 10-year CVD risk. Significant extra reduction in 10-year CVD risk without net HbA1c reduction supported that the goal of management of diabetic patients should not limited to HbA1c only.
DescriptionConference Theme: Innovations in Primary Care
Oral Presentation
Persistent Identifierhttp://hdl.handle.net/10722/191994

 

DC FieldValueLanguage
dc.contributor.authorFung, SCCen_US
dc.contributor.authorDai, Den_US
dc.contributor.authorKwok, RLPen_US
dc.contributor.authorTsui, ELHen_US
dc.contributor.authorWan, YFen_US
dc.contributor.authorWong, CKHen_US
dc.contributor.authorWong, Wen_US
dc.contributor.authorFong, DYTen_US
dc.contributor.authorLam, CLKen_US
dc.date.accessioned2013-10-15T07:46:12Z-
dc.date.available2013-10-15T07:46:12Z-
dc.date.issued2013en_US
dc.identifier.citationThe 3rd Hong Kong Primary Care Conference (HKPCC 2013), Hong Kong, 16 June 2013. In Programme book, 2013, p. 26en_US
dc.identifier.urihttp://hdl.handle.net/10722/191994-
dc.descriptionConference Theme: Innovations in Primary Care-
dc.descriptionOral Presentation-
dc.description.abstractINTRODUCTION: This study aimed to reveal the post 12-month effectiveness of the Multi-disciplinary Risk Assessment and Management Programme (RAMP) on diabetic patients. METHOD: Evaluation involved eleven clinics from four clusters of the Hospital Authority which had started RAMP before June 2010. A random sampling of 1248 patients enrolled into RAMP for more than one year was compared to age-sex, and disease-severity matched non-RAMP controls on clinical outcomes including HbA1c, blood pressure (BP), and low-density lipoprotein cholesterol (LDL-C), and the estimated 10-year cardiovascular disease (CVD) risk using Framingham risk scores equation to reveal the net benefit of RAMP. Independent t-test and Chi-square tests were used for comparison of continuous data and proportions, respectively. RESULTS: Both RAMP and non-RAMP patients showed a reduction in mean HbA1c, blood pressure, and LDL-C; and an increase in proportions of patients achieving target control of HbA1c ≤ 7%, BP ≤ 130/80 mmHg, and LDL-C ≤ 2.6 mmol/L). RAMP group did not show a significant net reduction in HbA1c compared to non-RAMP group but did show a significant net reduction of 2.61 (1.49) mmHg in SBP (DBP), and LDL-C of 0.17 mmol/L. RAMP reduce 10-year CVD risk by 4.66%, which significantly overwhelmed the 2.46% in control group by 2.2%. DISCUSSION: RAMP helped diabetic patients to improve their control of blood glucose, blood pressure, cholesterol level, and reduce their 10-year CVD risk. Significant extra reduction in 10-year CVD risk without net HbA1c reduction supported that the goal of management of diabetic patients should not limited to HbA1c only.-
dc.languageengen_US
dc.publisherHong Kong College of Family Physicians.-
dc.relation.ispartofHong Kong Primary Care Conference, HKPCC 2013en_US
dc.titleEffectiveness of the Multi-disciplinary Risk Assessment and Management Programme (RAMP) on Patients with Diabetic Mellitus – The First Year Experienceen_US
dc.typeConference_Paperen_US
dc.identifier.emailFung, SCC: cfsc@hku.hken_US
dc.identifier.emailWan, YF: yfwan@hku.hken_US
dc.identifier.emailWong, CKH: carlosho@hku.hken_US
dc.identifier.emailWong, W: wwong110@hku.hken_US
dc.identifier.emailFong, DYT: dytfong@hku.hken_US
dc.identifier.emailLam, CLK: clklam@hku.hken_US
dc.identifier.authorityFung, SCC=rp01330en_US
dc.identifier.authorityFong, DYT=rp00253en_US
dc.identifier.authorityLam, CLK=rp00350en_US
dc.identifier.hkuros226558en_US
dc.identifier.hkuros225579-
dc.publisher.placeHong Kong-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats